Last reviewed · How we verify

NCT04828902

Incidence of Postoperative Delirium After Cardiac Surgery in Adults.

Status unknown Last updated 15 April 2021
What this trial tests

trial testing cardiac surgery in Postoperative Delirium in 600 participants. Status unknown.

Timeline
1 February 2021
Primary endpoint
31 January 2022
31 August 2022

Quick facts

Lead sponsorMedical University of Gdansk
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment600
Start date1 February 2021
Primary completion31 January 2022
Estimated completion31 August 2022
Sites1 location across Poland

Drugs / interventions tested

Conditions studied

Sponsor

Medical University of Gdansk

Who can join

18 and older, any sex, with Postoperative Delirium or Adult Cardiac Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Postoperative delirium is an acute syndrome of mental deterioration characterized by acute onset and fluctuating course during the day. Very frequent delirium is a presage of other serious comorbidities i.e.: sepsis, acute kidney injury, circulatory and/or respiratory failure. A detailed knowledge of symptoms and early diagnose of delirium increase the chances of early therapy. To what extent the occurrence of postoperative delirium influences hospital therapy in the Cardiac Surgical Postoperative ICU in University Clinical Centre in Gdańsk is unknown so far.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of cardiac surgery

Trials testing the same drug.

Other recruiting trials for Postoperative Delirium

Currently open trials in the same condition.

Other Medical University of Gdansk trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04828902.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing